Aurobindo Pharma Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Unit-VI, Sy. No.329/39 & 329/47, Chitkul Village, Patancheru Mandal, Sanga Reddy District, Sangareddy, Telangana 502307, India (IND)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3004021263 · DUNS 918917639
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-09-29
- VAIDrug Quality Assurance2017-09-01
- NAIDrug Quality Assurance2014-12-09
- VAIDrug Quality Assurance2012-09-21
- OAIDrug Quality Assurance2010-12-22
Drugs this plant is listed as making
10 distinct drugs across 53 products name this site in their FDA label.
- CefadroxilAurobindo Pharma Limited
- CefdinirAurobindo Pharma Limited
- cefiximeAurobindo Pharma Limited
- Cefpodoxime ProxetilCronus Pharma LLC
- CefprozilAurobindo Pharma Limited
- Cefuroxime AxetilRising Pharma Holdings, Inc.
- CephalexinAurobindo Pharma Limited
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.